QGEN Nov 2024 45.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:07PM EDT. Market open.
Loading interactive chart...
- Simply Wall St.
Estimating The Fair Value Of Qiagen N.V. (NYSE:QGEN)
Key Insights Qiagen's estimated fair value is US$43.31 based on 2 Stage Free Cash Flow to Equity Qiagen's US$45.02...
- Zacks
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
- Zacks
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
© 2024 Yahoo. All rights reserved.